(Q34270559)

1 August 2017

1 reference

title

Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula (English)

1 reference

1 August 2017

1 reference

1

Allan D Sniderman

1 reference

1 August 2017

David Blank

2

1 reference

1 August 2017

Robert Zakarian

series ordinal

3

1 reference

1 August 2017

Jean Bergeron

series ordinal

4

1 reference

1 August 2017

Jiri Frohlich

series ordinal

5

1 reference

1 August 2017

1 October 2003

1 reference

1 August 2017

Clinical Biochemistry

1 reference

1 August 2017

36

1 reference

1 August 2017

499-504

1 reference

1 August 2017

7

1 reference

Calculated low-density lipoprotein cholesterol should not be used for management of lipoprotein abnormalities in patients with diabetes mellitus

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900117-6

Accuracy of calculated serum low-density lipoprotein cholesterol for the assessment of coronary heart disease risk in NIDDM patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900117-6

A more valid measurement of low-density lipoprotein cholesterol in diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900117-6

Estimation of VLDL cholesterol in hyperlipidemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900117-6

The Friedewald formula underestimates LDL cholesterol at low concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900117-6

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900117-6

Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900117-6

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900117-6

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900117-6

Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900117-6

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900117-6

Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900117-6

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900117-6

10.1016/S0009-9120(03)00117-6

7 January 2021

Identifiers

DOI

1 reference

1 August 2017

1 reference